Details

Snake venom c-type lectin-like protein Vaa-snaclec-3/2 efficiently prevents carotid artery thrombosis in a mouse model without compromising blood coagulation
ID Žužek, Monika C. (Author), ID Križaj, Igor (Author), ID Brvar, Miran (Author), ID Trobec, Tomaž (Author), ID Kranjc Brezar, Simona (Author), ID Dobaja, Mojca (Author), ID Leonardi, Adrijana (Author), ID Požek, Kity (Author), ID Vrecl, Milka (Author), ID Frangež, Robert (Author)

.pdfPDF - Presentation file, Download (7,59 MB)
MD5: DB783FA59139C9BF3B9F479F1DD33A3F
URLURL - Source URL, Visit https://www.mdpi.com/2072-6651/17/11/523 This link opens in a new window

Abstract
Platelets play pivotal roles in thromboembolic diseases, such as myocardial infarction and ischemic stroke. In patients envenomed by the snake Vipera a. ammodytes (Vaa), pronounced and transient thrombocytopenia without bleeding is observed. We previously showed that Vaa-snaclec-3/2, the snake venom C-type lectin-like protein, mediates this effect ex vivo. Here, we extended our study of the antithrombotic potential of this protein in vivo using a mouse model of ferric chloride (FeCl3)-induced carotid artery thrombosis. Prior to inducing thrombus formation, the mice received 1, 5, 10, 20, or 50 μg/kg Vaa-snaclec-3/2 intravenously. Afterward, the arterial blood flow was monitored with a perivascular Doppler probe. Additionally, the platelet count in the peripheral venous blood; tail bleeding time; and liver, lung, kidney, spleen, and heart histology were evaluated. The lowest dose of Vaa-snaclec-3/2 that we showed to cause severe thrombocytopenia and completely inhibit FeCl3-induced thrombus formation was 20 µg/kg. This dose prolonged the median tail bleeding time from 86.5 to 153.5 s but did not induce acute spontaneous hemorrhage, as demonstrated by histological analysis. Histology revealed no signs of apoptosis, necrosis or other degenerative changes in the inspected organs of mice exposed to 20 μg/kg Vaa-snaclec-3/2. Platelet clusters were observed only in the lungs, which appear to be the primary site of platelet sequestration and the cause of thrombocytopenia. Taken together, our findings highlight the high potential of Vaa-snaclec-3/2 as a safe and effective antithrombotic agent for the transient prevention of thrombosis in acute clinical settings.

Language:English
Keywords:snake venom, antithrombotic, snaclec, arterial thrombosis, mice
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:VF - Veterinary Faculty
MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2025
Number of pages:14 str.
Numbering:Vol. 17, iss. 11, art. 523
PID:20.500.12556/RUL-175410 This link opens in a new window
UDC:615:616-092:636.09
ISSN on article:2072-6651
DOI:10.3390/toxins17110523 This link opens in a new window
COBISS.SI-ID:254604035 This link opens in a new window
Publication date in RUL:20.11.2025
Views:351
Downloads:138
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Toxins. Elektronski vir
Shortened title:Toxins
Publisher:MDPI
ISSN:2072-6651
COBISS.SI-ID:517594649 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:kačji strup, kače, miši

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0053-2019
Name:Endokrini, imunski in encimski odzivi pri zdravih in bolnih živalih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0207-2020
Name:Toksini in biomembrane

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0019-2019
Name:Aplikativna in bazična fiziologija in patofiziologija v medicini

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-2534-2020
Name:Reverzibilnost prehodne trombocitopenije izzvane s komponento kačjega strupa ponuja varno antitrombotično preventivo v interventni angiologiji in kardiologiji

Funder:ARRS - Slovenian Research Agency
Funding programme:Slovenian Research and Innovation Agency
Project number:1000-22-0106
Name:1000-22-0106

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back